Processing and delivery of peptides presented by MHC class I molecules

Current Opinion in Immunology

Volumn 8, Issue 1, 1996, Pages 59-67

  Lehner, Paul J ^a   Cresswell, Peter ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CARRIER PROTEIN; EPITOPE; GAMMA INTERFERON; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; PEPTIDE; PROTEASOME;

ANTIGEN PRESENTATION; ENDOPLASMIC RETICULUM; GENETIC ANALYSIS; MAJOR HISTOCOMPATIBILITY COMPLEX; PROTEIN DEGRADATION; REVIEW;

EID: 0029917002     PISSN: 09527915     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0952-7915(96)80106-3     Document Type: Article

References (84)

1. Howard JC: Supply and transport of peptides presented by class I MHC molecules. Curr Opin Immunol 1995, 7:69-76.
2. Townsend A, Bastin J, Gould K, Brownlee G, Andrew M, Coupar B, Boyle D, Chan S, Smith G: Defective presentation to class I-restricted cytotoxic T lymphocytes in vaccinia-infected cells is overcome by enhanced degradation of antigen. J Exp Med 1988, 168:1211-1224.
3. Wright KL, White LC, Kelly A, Beck S, Trowsdale J, Ting JP-Y: Coordinate regulation of the human TAP1 and LMP2 genes from a shared bidirectional promoter. J Exp Med 1995, 181:1459-1471.
4. Löwe J, Stock D, Jap B, Zwickl P, Baumeister W, Huber R: Crystal structure of the 20S proteasome from the archaeon T. acidophilum at 3.4 Ȧ resolution. Science 1995, 268:533-539. Describes the X-ray cristallographic analysis of an archaebacterium 20S proteasome. The binding of a peptide aldehyde inhibitor identifies the active site on the β subunit in the central cavity of the protease complex.
5. Wenzel T, Baumeister W: Conformational constraints in protein degradation by the 20S proteasome. Struct Biol 1995, 2:199-204. This paper shows that complete unfolding of α-lactalbumin is required for its access to the orifice of the proteasome peptide channel and subsequent degradation.
6. Seemüller E, Lupas A, Stock D, Löwe J, Huber R, Baumeister W: Proteasome from Thermoplasma acidophilum: a threonine protease. Science 1995, 268:579-582. Site-directed mutagenesis on the 20S proteasome shows it to be a threonine protease. Deletion of the β subunit amino-terminal threonine, or mutation to an alanine, inactivates the enzyme.
7. Vinitsky A, Cardozo C, Sepp-Lorenzino L, Michaud C, Orlowski M: Inhibition of the proteolytic activity of the multicatalytic proteinase complex (proteasome) by substrate-related peptide aldehydes. J Biol Chem 1994, 269:29860-29866.
8. b class I molecules.
9. Fenteany G, Standaert RF, Lane WS, Choi S, Corey EJ, Schreiber SL: Inhibition of proteasome activities and subunit-specific amino-terminal threonine modification by lactacystin. Science 1995, 268:726-731.
10. •], that individual MHC-encoded proteasome subunits effect the presentation of some but not all antigenic peptides.
11. •].
12. Kuckeihom LJ, Frentzel S, Kraft R, Kostka S, Groettrup M, Kloetzel PM: Incorporation of major histocompatibility complex-encoded subunits LMP2 and LMP7 changes the quality of the 20S proteasome polypeptide processing products Independent of interferon-γ. Eur J Immunol 1995, 25:2605-2611.
13. Arnold D, Driscoll P, Androlewicz M, Hughes E, Cresswell P, Spies TA: Proteasome subunits encoded in the MHC are not generally required for the processing of peptides bound by MHC class I molecules. Nature 1992, 360:171-173.
14. Momburg F, Ortiz-Navarrete V, Neefjes J, Goulmy E, Vandewal Y, Spits H, Powis SJ, Butcher GW, Howard JC, Walden P, Hämmerling GJ: The proteasome subunits encoded by the major histocompatibility complex are not essential for antigen presentation. Nature 1992, 360:174-177.
15. Yewdell J, Lapham C, Bacik I, Spies T, Bennink J: MHC-encoded proteasome subunits LMP-2 and LMP-7 are not required for efficient antigen presentation. J Immunol 1994, 152:1163-1170.
16. Belich MP, Glynne RJ, Senger G, Sheer D, Trowsdale J: Proteasome components with reciprocal expression to that of the MHC-encoded LMP proteins. Curr Biol 1994, 4:769-776.
17. Früh K, Gossen M, Wang KN, Bujard H, Peterson PA, Yang Y: Displacement of housekeeping proteasome subunits by MHC-encoded LMPs-a newly discovered mechanism for modulating the multlcatalytlc proteinase complex. EMBO J 1994, 13:3236-3244.
18. Gaczynska M, Rock K, Goldberg A: Gamma-interferon and expression of MHC genes regulate peptide hydrolysis by proteasomes. Nature 1993, 365:264-267.
19. Gaczynska M, Rock KL, Spies T, Goldberg AL: Peptidase activities of proteasomes are differentially regulated by the major histocompatibility complex-encoded genes for LMP-2 and LMP-7. Proc Natl Acad Sci USA 1994, 91:9213-9217.
20. Driscoll J, Brown M, Finley D, Monaco J: MHC-linked LMP gene products specifically alter peptidase activities of the proteasome. Nature 1993, 365:252-264.
21. Boes B, Hengel H, Ruppert T, Multhaup G, Koszinowski UH, Kloetzel PM: Interferon γ stimulation modulates the proteolytic activity and cleavage site preference of 20S mouse proteasomes. J Exp Med 1994, 179:901-909.
22. Chu-Ping M, Willy PJ, Slaughter CA, DeMartino GN: PA2B, an activator of the 20S proteasome, is inactivated by proteolytic modification at its carboxyl terminus. J Biol Chem 1993, 268:22514-22519.
23. •] this paper suggests that the IFN-γ induced effects on peptide cleavage may be a combined response to LMP2, LMP7 and the 11S regulator.
24. Mott JD, Pramanik BC, Moomaw CR, Afendis SJ, DeMartino GN, Slaughter CA: PA28, an activator of the 20S proteasome, is composed of two nonidentical but homologous subunits. J Biol Chem 1994, 269:31466-31471.
25. Gray CW, Slaughter CA, DeMartino GN: PA28 activator protein forms regulatory caps on proteasome stacked rings. J Mol Biol 1994, 236:7-15.
26. Ustrell V, Pratt G, Rechsteiner M. Effects of Interferon γ and major histocompatibility complex-encoded subunits on peptidase activities of human multicatalytic proteases. Proc Natl Acad Sci USA 1995, 92:584-588.
27. •,26] these results suggest that all three components are responsible for the changes induced by IFN-γ.
28. Del Val M, Schlicht H-J, Ruppert T, Reddehase MJ, Koszinowski UH: Efficient processing of an antigenic sequence for presentation by MHC class I molecules depends on its neighboring residues in the protein. Cell 1991, 66:1145-1153.
29. Eisenlohr LC, Yewdell JL, Bennink J: Flanking sequences influence the presentation of an endogenously synthesized peptide to cytotoxic T lymphocytes. J Exp Med 1992, 175:481-487
30. + T cell recognition of an endogenously processed epitope is regulated primarily by residues within the epitope. J Exp Med 1992, 176:1335-1341.
31. Eggers M, Boes-Fabian B, Ruppert T, Kloetzel P-M, Koszinowski UH: The cleavage preference of the proteasome governs the yield of antigenic peptides. J Exp Med 1995, 182:1865-1870.
32. Niedermann G, Butz S, Ihlenfeldt HG, Grimm R, Lucchiari M, Hoschützky H, Jung G, Maier B, Eichmann, K: Contribution of proteasome-mediated proteolysis to the hierarchy of epitopes presented by major histocompatibillty complex class I molecules. Immunity 1995, 2:289-299.
33. Villanueva MS, Fischer P, Feen K, Pamer EG: Efficiency of MHC class I antigen processing: a quantitative analysis. Immunity 1994, 1:479-489. The first accurate quantitation of the efficiency of class I restricted antigen processing.
34. Michalek MT, Grant EP, Gramm C, Goldberg AL, Rock KL: A role for the ubiquitin-dependent proteolytic pathway in MHC class I-restricted antigen presentation. Nature 1993, 363:552-554.
35. Cox JH, Galardy P, Bennink JR, Yewdell JW: Presentation of endogenous and exogenous antigens is not affected by inactivation of E1 ubiquitin-activating enzyme in temperature-sensitive cell lines. J Immunol 1995, 154:511-519. This paper, in contrast to [34], finds no evidence for antigen-processing defects in two mutant cell lines with temperature-sensitive E1 proteins. Temperature-sensitive cell lines are shown to maintain the capacity to ubiquitinate proteins at non-permissive temperatures.
36. Grant EP, Michalek MT, Goldberg AL, Rock KL: Rate of antigen degradation by the ubiquitin-protease pathway influences MHC class I presentation. J Immunol 1995, 155:3750-3758.
37. Falk K, Rötzschke O, Rammensee HG: Cellular peptide composition governed by major histocompatibility complex class I molecules. Nature 1990, 348:248-251.
38. Urban RG, Chicz RM, Lane WS, Strominger JL, Rehm A, Kenter MJH, Uytedhaag FGCM, Ploegh H, Uchanska-Ziegler B, Ziegler A: A subset of HLA-B27 molecules contains peptides much longer than nonamers, Proc Natl Acad Sci USA 1994, 91:1534-1538.
39. Bouvier M, Wiley DC: Importance of peptide amino and carboxyl termini to the stability of MHC class I molecules. Science 1994, 265:398-402.
40. Eisenlohr LC, Bacik I, Bennink JR, Bernstein K, Yewdell JW: Expression of a membrane protease enhances presentation of endogenous antigens to MHC class I-restricted T lymphocytes. Cell 1992, 71:963-972.
41. Wei ML, Cresswell P: HLA-A2 molecules in an antigen-processing mutant cell contain signal sequence-derived peptides. Nature 1992, 356:443-446.
42. Henderson RA, Michel H, Sakaguchi K, Shabanowitz J, Appella E, Hunt DF, Engelhard VH: HLA-A2.1-associated peptides from a mutant cell line: a second pathway of antigen presentation. Science 1992, 255:1264-1267.
43. Snyder HL, Yewdell JW, Bennink JR: Trimming of antigenic peptides in an early secretory compartment J Exp Med 1994, 180:2389-2394.
44. Elliott T, Willis A, Cerundolo V, Townsend A: Processing of major histocompatibility class I-restricted antigens in the endoplasmic reticulum. J Exp Med 1995, 181:1481-1491.
45. Roelse J, Grommé M, Momburg F, Hämmerling G, Neefjes J: Trimming of TAP-translocated peptides in the endoplasmic reticulum and in the cytosol during recycling. J Exp Med 1994, 180:1591-1597. This paper shows that peptides translocated into the ER, which do not bind class I, are released from the ER by an ATP-dependent, TAP-independent mechanism.
46. •], this paper demonstrates a TAP-dependent mechanism by which phagocytosed antigen may gain access to the MHC class I pathway.
47. •].
48. Skipper JCA, Hendrickson RC, Gulden PH, Brichard V, Van Pel A, Chen Y, Shabanowitz J, Wolfel T, Slingluff CL Jr, Boon T et al.: HLA-A2 restricted tyrosinase antigen on melanoma cells results from post-translational modification. 1996, in press. This paper demonstrates post-translational modification of a naturally processed class I peptide. The conversion of an asparagine to an aspartic acid is of central importance for peptide recognition by melanoma specific T cells.
49. + T cells. Nature 1993, 364:158-161.
50. Van Binnendijk RS, van Baalen CA, Poelen MC, De Vries P, Boes J, Cerundolo V, Osterhaus AD, UyteHaag FG: Measles virus transmembrane fusion protein synthesized de novo or presented in immunostimulating complexes is endogenously processed for HLA class I- and class II-restricted cytotoxic T cell recognition. J Exp Med 1992, 176:119-128.
51. Androlewicz MJ, Ortmann B, van Endert PM, Spies T, Cresswell P: Characteristics of peptide and class I/β2m binding to the transporters associated with antigen processing (TAP.1 and TAP.2). Proc Natl Acad Sci USA 1994, 91:12716-12720. Together with [63] this paper shows the association of MHC class I molecules with TAP1. A combinatorial peptide-binding site involving TAP1 and TAP2 is demonstrated.
52. Meyer TH, Van Endert PM, Uebel S, Ehring B, Tampé R: Functional expression and purification of the ABC transporter complex associated with antigen processing (TAP) in insect cells. FEBS Lett 1994, 351:443-447.
53. Van Endert P, Tampé R, Meyer TH, Tisch R, Bach J-F, McDevitt HO: A sequential model for peptide binding and transport by the transporters associated with antigen processing. Immunity 1994, 1:491-500.
54. Uebel S, Meyer TH, Kraas W, Kienle S, Jung G, Wiesmüller K-H, Tampé R; Requirements for peptide binding to the human transporter associated with antigen processing revealed by peptide scans and complex peptide libraries. J Biol Chem 1995, 270:18512-18516.
55. Wang K, Früh K, Peterson PA, Yang Y: Nucleotide binding of the C-terminal domains of the major histocompatibility complex-encoded transporter expressed in Drosophita melanogaster cells. FEBS Lett 1994, 350:337-341.
56. Van Endert P, Riganelli D, Greco Giulia, Fleischhauer K, Sidney J, Sette A, Bach J-F: The peptide-binding motif for the human transporter associated with antigen processing. J Exp Med 1995, 182:1883-1895.
57. Neisig A, Roelse J, Sijts AJAM, Ossendorp F, Feltkamp MCW, Kast WM, Melief CJM, Neefjes JJ: Major differences in transporter associated with antigen presentation (TAP)-dependent translocation of MHC class I-presentable peptides and the effect of flanking sequences. J Immunol 1995, 154:1273-1279.
58. 32P]ATP.
59. Rivett AJ, Palmer A, Knecht E: Electron microscopic localization of the multicatalytic proteinase complex in rat liver and in cultured cells. J Histochem Cytochem 1992, 40:1165-1172.
60. Srivastava PK, Udono H, Blachere NE, Li Z: Heat shock proteins transfer peptides during antigen processing and CTL priming. Immunogenetics 1994, 39:93-98.
61. Suto R, Srivastava PK: A mechanism for the specific immunogenlcity of heat shock protein-chaperoned peptides. Science 1995, 269:1585-1588.
62. Ortmann B, Androlewicz M, Cresswell P: MHC class I/β2-microglobulin complexes associate with TAP transporters before peptide binding. Nature 1994, 368:864-867.
63. Suh W-K, Cohen-Doyle MF, Früh K, Wang K, Peterson PA, Williams DB: Interaction of MHC class I molecules with the transporter associated with antigen processing. Science 1994, 264:1322-1326.
64. ••] shows the importance of class I-TAP interaction.
65. •]) is shown to prevent MHC class I-TAP interaction. The unidentified gene is MHC-linked.
66. 2-microglobulin. J Biol Chem 1995, 270:19638-19642.
67. 2-microglobulin: major histocompatibility complex class I heavy chain intermediate dissociates from calnexin and then is stablized by binding peptide. J Exp Med 1994, 180:2163-2171.
68. Nöbner E, Parham P: Species specific differences in chaperone interaction of human and mouse major histocompatibility complex class I molecules. J Exp Med 1995, 181:327-337.
69. Carreno BM, Soiheim JC, Harris M, Stroynowski I, Connolly JM, Hansen TH: TAP associates with a unique class I conformation, whereas calnexin associates with multiple class I forms in mouse and man. J Immunol 1995, 155:4726-4753.
70. •], shows that MHC class I molecules can assemble and be transported in the absence of the chaperone, calnexin.
71. •].
72. Day PM, Esquivel F, Lukszo J, Bennink JR, Yewdell JW: Effect of TAP on the generation and intracellular trafficking of peptide-receptive major histocompatibility complex class I molecules. Immunity 1995, 2:137-147.
73. Khanna R, Burrows SR, Argaet V, Moss DJ: Endoplasmic reticulum signal sequence facilitated transport of peptide epitopes restores immunogenicity of an antigen processing defective tumour cell line, Int Immunol 1994, 6:639-645.
74. Rowe M, Khanna R, Jacob CA, Argaet V, Kelly A, Powis S, Belich M, Croom-Carter D, Lee S, Burrows SR et al.: Restoration of endogenous antigen processing in Burkitt's lymphoma cells by Epstein-Barr virus latent membrane protein-1: coordinate up-regulation of peptide transporters and HLA-class I antigen expression. Eur J Immunol 1995, 25:1374-1384.
75. Levitskaya J, Coram M, Levitsky V, Imreh S, Steigerwald-Mullen PM, Klein G, Kurilla MG, Masucci MG: Inhibition of antigen processing by the internal repeat region of the Epstein-Barr virus nuclear antigen-1. Nature 1995, 375:685-688. The EBNA 1 protein is detected in all EBV-associated malignancies, but does not elicit a detectable CTL response. This paper suggests that the internal glycine-alanine repeat region of EBNA-1 prevents processing of epitopes from within the protein.
76. ••], this paper shows that the Herpes simplex derived protein (ICP47) prevents class I presentation by inhibiting TAP-dependent peptide translocation.
77. ••].
78. + T lymphocytes. Cell 1994, 77:523-535. The MHC class I downregulation which follows infection with herpes simplex virus is shown to be caused by an immediate early gene encoding the 9 kDa ICP47 protein.
79. Beersma MF, Bijlmakers MJ, Ploegh HL: Human cytomegalovirus down-regulates HLA class I expression by reducing the stability of class I H chains. J Immunol 1993, 151:4455-4464.
80. Warren AP, Ducroq DH, Lehner PJ, Borysiewicz LK: Human cytomegalovirus-infected cells have unstable assembly of major histocompatibility complex class I complexes and are resistant to lysis by cytotoxic T lymphocytes. J Virol 1994, 68:2822-2829.
81. Del Val M, Munch K, Reddehase MJ, Koszinowski UH: Presentation of CMV immediate-early antigen to cytolytic T lymphocytes is selectively prevented by viral genes expressed in the early phase. Cell 1989, 58:305-315.
82. Hill A, Ploegh H: Getting the inside out: the transporter associated with antigen processing (TAP) and the presentation of viral antigen. Proc Natl Acad Sci USA 1995, 92:341-343.
83. Thäle R, Szepan U, Hengel H, Geginat G, Lucin P, Koszinowski UH: Identification of the mouse cytomegalovirus genomic region affecting major histocompatibility complex class I molecule transport. J Virol 1995, 69:6098-6015. This paper identifies the mouse CMV genomic region causing ER retention of MHC class I molecules and identifies a late mechanism that downregulates MHC class I molecules.
84. Müllbacher A, Lobigs M: Up-regulation of MHC class I by flavivirus-induced peptide translocation into the endoplasmic reticulum. Immunity 1995, 3:207-214.